Pricing Log in Create free account
Saturday 17 October 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.71 0.86 −1.42%
Market cap
$123.7B
P/E
13.2×
Fwd P/E
11.2×
Dividend yield
4.22%
F-score
8/9
Altman Z
2.14
Beneish M
−2.69
Dividend safety
63/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bristol Myers Squibb Company (BMY) Net margin

Alert me on Net margin

Bristol Myers Squibb Company's net margin over the twelve months to 30 June 2026 was 18.9%, up 4.2 percentage points from fiscal 2025 (14.6%). Over the past ten years it has ranged from −21.2% (fiscal 2020) to 22.9% (fiscal 2016); the current reading is higher than 64% of that period. That is above the Drug Manufacturers General industry median of 8.27% and above the Healthcare sector median of 0.00%.

Net margin, annual

Embed this chart

Annual newest first

Period Net margin Change (points)
FY2025 14.6% 33.17
FY2024 −18.5% (36.36)
FY2023 17.8% 4.12
FY2022 13.7% (1.37)
FY2021 15.1% 36.28
FY2020 −21.2% (34.35)
FY2019 13.2% (8.66)
FY2018 21.8% 16.96
FY2017 4.85% (18.09)
FY2016 22.9% 13.49

Quarterly newest first

Period Net margin Change (points)
Jun 2026 25.6% 2.27
Mar 2026 23.3% 14.61
Dec 2025 8.69% (9.32)
Sep 2025 18.0% 7.33
42 more quarters

Against its own ten years

Low −21.2% High 22.9%
Ten-year median 13.7%
Current reading's percentile 81

Net margin against peers

Company Net margin
NVO Novo Nordisk A/S compare 35.5%
AMGN Amgen Inc. compare 23.0%
NVS Novartis AG compare 22.5%
BMY Bristol Myers Squibb Company 18.9%
AZN AstraZeneca PLC compare 17.0%
GSK GSK PLC Sponsored ADR compare 14.6%
SNY Sanofi compare 8.22%
PFE Pfizer Inc. compare 6.80%
GILD Gilead Sciences, Inc. compare −10.6%
Drug Manufacturers General industry median 8.27%
Healthcare sector median 0.00%
Market median 0.45%

What Net margin is

Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.

Net Income Allotted to Shareholders ÷ Revenue

The full definition of Net margin →

More on BMY